Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Daniel T. Starczynowski, PHD |
CPD Achievement award |
The Leukemia and Lymphoma Society |
Starczynowski, D., L |
1/1/21-12/31/21 |
$5,000 |
Marie-Dominique Filippi, PHD |
Role of a common leptin recept |
Cincinnati Veterans Administration |
VA, Filippi, M. |
9/1/21-8/31/22 |
$6,644 |
Andrew Harley, PHD |
Training grant |
National Institutes of Health (NIH)/University of Cincinnati |
1017546 |
3/14/22-8/31/22 |
$24,816 |
Kenneth J Campbell, PHD |
The role of chromatin assembly |
National Institutes of Health (NIH) |
2R01MH090740 |
5/1/22-4/30/23 |
$289,417 |
Andrew Volk, PHD |
The role of chromatin assembly |
Ohio Cancer Research Associates |
Volk, A. OCR |
7/1/21-6/30/22 |
$30,000 |
Jennifer PatrittiCram |
Understanding the role of puri |
The Children's Tumor Foundation |
2020-01-006 |
7/1/21-6/30/22 |
$32,000 |
Abhishek Singh |
Molecular mechanisms controlli |
American Society of Hematology |
ASH_SINGH |
7/1/21-6/30/22 |
$38,095.77 |
Nancy Ratner, PHD |
Novel eIF4A inhibitors rocagla |
Cancer Free Kids |
Ratner, N., CFK |
1/1/22-12/31/22 |
$40,000 |
LEI HUANG, MD |
Neuron- and microglia-specific |
National Institutes of Health (NIH)/University of Cincinnati |
012928-002 |
3/1/21-2/28/22 |
$44,123 |
Nancy Ratner, PHD |
RAS-specific combination thera |
Cancer Free Kids |
Ratner, N., CFK |
7/1/21-6/30/22 |
$46,000 |
Oluwabukola T Gbotosho, PHD |
Role of macrophages in inflamm |
American Society of Hematology |
Gbotosho, O., ASH |
7/1/21-6/30/22 |
$50,000 |
FuKun Guo, PHD |
Preclinical treatment with dig |
Cancer Free Kids |
Huang, L. CFK |
1/1/22-12/31/22 |
$50,000 |
Lai Man Wu, PHD |
Targeting tumor-initiating ste |
Cancer Free Kids |
Wu,. L., CFK |
7/1/21-3/31/23 |
$50,000 |
ZHAOWEI TU, PHD |
Overcoming chemo-resistant RUN |
Cancer Free Kids |
Tu, Z., CFK |
1/1/22-12/31/22 |
$50,000 |
Qing Richard Lu, PHD |
Targeting medulloblastomas wit |
Cancer Free Kids |
Lu, Q., CFK |
7/1/21-6/30/22 |
$50,000 |
Marie-Dominique Filippi, PHD |
Exploiting metabolic vulnerabi |
Cancer Free Kids |
Filippi, M., CFK |
1/1/22-12/31/22 |
$50,000 |
Andrew Volk, PHD |
The chromatin assembly complex |
Cancer Free Kids |
Volk, A., CFK |
7/1/21-6/30/23 |
$50,000 |
Lai Man Wu, PHD |
Identification of cellular div |
Pablove Foundation |
Wu, Pablove fdn |
7/1/21-6/30/22 |
$52,500 |
LEI HUANG, MD |
Identification of causal facto |
National Institutes of Health (NIH)/University of Cincinnati |
013249-002 |
7/1/21-6/30/22 |
$55,230 |
Kalen P Berry, PHD |
Training grant |
National Institutes of Health (NIH)/University of Cincinnati |
1014415 |
9/1/21-8/31/22 |
$56,712 |
Kye Stachowski, PHD |
Training grant |
National Institutes of Health (NIH)/University of Cincinnati |
1017278 |
10/15/21-6/30/22 |
$57,671 |
Joon Bae Seo, PHD |
Training Grant |
National Institutes of Health (NIH)/University of Cincinnati |
1016232 |
7/1/21-3/14/22 |
$59,581 |
Jenny Yeung, PHD |
The role of GPR56 in platelet |
National Institutes of Health (NIH) |
F32HL149280 |
11/9/20-7/31/22 |
$68,000 |
Sandra Schrenk, PHD |
Semaphorin 3A and 3F in TIE2-m |
American Heart Association - National |
833891 |
4/1/22-3/31/23 |
$71,306 |
Lai Man Wu, PHD |
Identification of cellular het |
Department of Defense Army |
W81XWH2010443 |
6/1/21-5/31/22 |
$79,500 |
Robert Francis Hennigan, PHD |
Regulation of Translation by N |
Department of Defense Army |
W81XWH2210196 |
5/1/22-4/30/23 |
$79,500 |
Qing Richard Lu, PHD |
Targeting pineoblastoma with n |
St. Baldrick's Foundation |
847260 |
7/1/21-6/30/22 |
$100,000 |
Andrew Volk, PHD |
The chromatin assembly complex |
The V Foundation |
V2021-012 |
11/1/21-10/31/22 |
$100,000 |
Daniel Lucas, PHD |
Leukemia and Lymphoma Society |
The Leukemia and Lymphoma Society |
1380-22 |
10/1/21-9/30/22 |
$119,999 |
Jizhou Zhang |
Investigating the mechanism of |
Edward P. Evans Foundation |
Zhang, J., EPEF |
7/1/21-6/30/22 |
$125,000 |
Timothy M Chlon, PHD |
Modeling DDX41-mutated Myelody |
Edward P. Evans Foundation |
Chlon, Tim, EPEF |
7/1/21-6/30/22 |
$145,520 |
Timothy M Chlon, PHD |
The Role of DDX41 in Inherited |
National Institutes of Health (NIH) |
K01DK121733 |
8/1/21-7/31/22 |
$150,444 |
Yi Zheng, PHD |
Rational Targeting Oncogenic K |
Department of Defense Army/University of Wisconsin-Madison |
812 |
8/1/21-7/31/22 |
$160,000 |
LEI HUANG, MD |
Evaluating the therapeutic pot |
Department of Defense Army |
W81XWH2010870 |
9/1/21-8/31/22 |
$190,797 |
Richard Lang, PHD |
Light regulated vascular devel |
National Institutes of Health (NIH) |
R01EY032029 |
1/1/22-12/31/22 |
$194,555 |
Daniel T. Starczynowski, PHD |
Exploring the contribution of |
Edward P. Evans Foundation |
Starczynowski, D., E |
9/1/21-8/31/22 |
$200,000 |
Nancy Ratner, PHD |
Developing novel biomarkers of |
National Institutes of Health (NIH)/Ann & Robert H Lurie Children's Hospital |
901654-CHMC |
12/7/21-5/31/22 |
$234,010 |
Ronald R Waclaw, PHD |
Genetic approaches to address |
National Institutes of Health (NIH) |
R21NS123974 |
3/1/22-2/28/23 |
$238,500 |
Marie-Dominique Filippi, PHD |
The role of mitochondria in bo |
Department of Defense Army |
W81XWH2010689 |
8/1/21-7/30/22 |
$239,199 |
Benjamin E Tourdot, PHD |
The racial disparity in platel |
National Institutes of Health (NIH) |
R00HL136784 |
4/1/22-3/31/23 |
$249,000 |
Andrew Volk, PHD |
The Role of CHAF1B in Maintain |
National Institutes of Health (NIH) |
R00CA230314 |
6/1/21-5/31/22 |
$249,000 |
Nancy Ratner, PHD |
Single cell analyses of NF1 pl |
Department of Defense |
W81XWH1910816 |
9/30/21-9/29/22 |
$255,360 |
Harry Leighton Grimes, PHD |
Regulation of functionally discrete hematopietic s |
National Institutes of Health (NIH) |
R01DK121062 |
1/1/22-12/31/22 |
$260,848 |
John E Robinson |
Leveraging systemic AAV vector |
Simons Foundation |
663007 |
1/1/22-12/31/22 |
$298,334 |
Paul Andreassen, PHD |
Functional characterization of |
National Institutes of Health (NIH) |
R01GM134731 |
6/1/21-5/31/22 |
$310,017 |
Punam Malik, MD |
Reducing Error-Prone Repair Si |
Doris Duke Charitable Foundation |
DorisDukes - Punam,M |
9/1/21-8/31/22 |
$330,000 |
Stella M Davies, MD |
Randomized trial of viral spec |
National Institutes of Health (NIH) |
U01AI157620 |
7/1/21-4/30/22 |
$354,337.50 |
John E Robinson |
Optimized AAV vectors for ther |
Gilbert Family Foundation Gene Therapy I |
521007 |
12/1/21-11/30/22 |
$368,198 |
Jianqiang Wu, MD |
Targeting complement 5a-mediat |
National Institutes of Health (NIH) |
R33NS112407 |
3/1/22-2/28/23 |
$397,451 |
Andrew Volk, PHD |
How CHAF1B maintains cell stat |
National Institutes of Health (NIH) |
1R35GM142452-01 |
9/15/21-8/31/22 |
$397,500 |
FuKun Guo, PHD |
The role of transcription elon |
National Institutes of Health (NIH) |
R01CA234038 |
5/1/22-4/30/23 |
$437,202 |
Ronald R Waclaw, PHD |
Impact of Lztr1 mutations on o |
National Institutes of Health (NIH) |
1R21NS125347-01 |
9/20/21-2/28/23 |
$437,250 |
James Mulloy, PHD |
Leukemia stem cell polarity and differentiation therapy |
National Institutes of Health (NIH) |
R01CA204895 |
8/1/21-7/31/22 |
$442,805 |
Nancy Ratner, PHD |
Mitogenic Activities in Neurofibromatosis |
National Institutes of Health (NIH) |
R01NS028440 |
7/1/21-6/30/22 |
$445,976 |
Nicolas Nassar, PHD |
Targeted Inhibition in Leukemi |
National Institutes of Health (NIH) |
R01CA237016 |
7/1/21-6/30/22 |
$465,554 |
Nancy Ratner, PHD |
Identification of novel pathwa |
National Institutes of Health (NIH) |
R01NS120892 |
12/1/21-11/30/22 |
$500,637 |
Yi Zheng, PHD |
Novel mechanism of intestinal |
National Institutes of Health (NIH) |
R01AG063967 |
6/1/21-5/31/22 |
$505,734 |
Daniel Lucas, PHD |
Spatial control of myeloid dif |
National Institutes of Health (NIH) |
R01HL153229 |
8/15/21-7/31/22 |
$512,253 |
Daniel Lucas, PHD |
Hematopoietic Stem Cell engraf |
National Institutes of Health (NIH) |
R01HL162649 |
4/1/22-3/31/23 |
$526,265 |
Robert Francis Hennigan, PHD |
Merlin-ASPP2 Tumor Suppressor |
Department of Defense Army |
W81XWH2010377 |
5/15/21-5/14/22 |
$556,500 |
Jose Cancelas-Perez, MD-PHD |
Mitochondria mediated intercel |
National Institutes of Health (NIH) |
R01DK124115 |
5/1/21-4/30/22 |
$559,680 |
Yi Zheng, PHD |
Small molecules targeting RhoA |
National Institutes of Health (NIH) |
R01HL147536 |
3/1/22-2/28/23 |
$571,944 |
Marie-Dominique Filippi, PHD |
The role of mitochondria in he |
National Institutes of Health (NIH) |
RHL151654A |
1/1/22-12/31/22 |
$607,687 |
Elisa Boscolo, PHD |
Venous Malformations (VM): A M |
National Institutes of Health (NIH) |
R01HL117952 |
2/1/22-1/31/23 |
$635,998 |
Daniel T. Starczynowski, PHD |
Decoding innate immune signaling in normal and myelodysp |
National Institutes of Health (NIH) |
R35HL135787 |
1/1/22-12/31/22 |
$644,361 |
Daniel T. Starczynowski, PHD |
Dissecting innate immune signa |
National Institutes of Health (NIH) |
R01CA271455 |
3/4/22-2/28/23 |
$652,991 |
Nancy Ratner, PHD |
Uncovering treatment targets f |
National Institutes of Health (NIH)/University of Minnesota |
1R01NS115438-01A1 |
7/1/21-6/30/22 |
$692,697 |
Yi Zheng, PHD |
Cincinnati Cooperative Center |
National Institutes of Health (NIH) |
U54DK126108 |
8/1/21-7/31/22 |
$852,127 |
Daniel Lucas, PHD |
Role of the local vascular mic |
National Institutes of Health (NIH) |
R01HL158616 |
6/1/22-5/31/23 |
$1,137,784 |
Total Annual Grant Award Dollars |
$18,339,610.27 |